Internal Assessment for 2011 International Review - CIHR Institute of Cancer Research - Long Descriptions
Figure 1: CIHR expenditures and number of grants relevant to ICR mandate, by fiscal year
| fiscal year |
2000-01 |
2001-02 |
2002-03 |
2003-04 |
2004-05 |
2005-06 |
2006-07 |
2007-08 |
2008-09 |
2009-10 |
| grant $ open |
40,670 |
50,657 |
56,351 |
62,240 |
69,192 |
75,181 |
82,663 |
88,091 |
95,290 |
95,862 |
| grant $ strategic |
4,096 |
7,714 |
15,697 |
20,282 |
23,462 |
25,266 |
26,102 |
28,973 |
26,573 |
24,380 |
| grant # open |
517 |
569 |
587 |
649 |
683 |
744 |
789 |
824 |
831 |
813 |
| grant # strategic |
47 |
92 |
116 |
159 |
180 |
197 |
216 |
184 |
243 |
235 |
« Back to figure 1
Figure 2: Percentage of total CIHR expenditures related to ICR mandate areas over time
| fiscal year |
2000-01 |
2001-02 |
2002-03 |
2003-04 |
2004-05 |
2005-06 |
2006-07 |
2007-08 |
2008-09 |
2009-10 |
| grant $ open |
16.45% |
16.55% |
16.51% |
17.47% |
18.34% |
18.76% |
19.71% |
19.56% |
20.06% |
20.46% |
| grant $ strategic |
13.51% |
11.37% |
14.93% |
14.56% |
14.68% |
14.45% |
13.78% |
14.04% |
11.25% |
10.20% |
| salary $ open |
19.60% |
19.43% |
19.26% |
19.06% |
19.14% |
17.41% |
18.05% |
19.19% |
19.61% |
20.67% |
| salary $ strategic |
18.56% |
12.66% |
12.11% |
11.58% |
8.56% |
11.38% |
12.33% |
10.19% |
9.74% |
9.61% |
| training $ open |
18.91% |
18.46% |
18.50% |
18.31% |
18.14% |
21.42% |
21.72% |
22.75% |
21.14% |
20.55% |
| training $ strategic |
8.59% |
11.00% |
9.66% |
11.94% |
12.82% |
11.48% |
10.57% |
8.77% |
6.01% |
7.38% |
« Back to figure 2
Figure 3: Specialization index and average of relative citations for top 10 countries publishing in PEOLC, 2000–2008
| Years |
Country |
Research Area |
Papers |
ARIF |
ARC |
SI |
| 2000 to 2008 |
World |
CIHR_Cancer |
4561 |
1 |
1.000001 |
1 |
| 2000 to 2008 |
United States |
CIHR_Cancer |
1212 |
1.308096 |
1.316474 |
0.834201 |
| 2000 to 2008 |
United Kingdom |
CIHR_Cancer |
628 |
0.980288 |
0.960766 |
1.622083 |
| 2000 to 2008 |
Germany |
CIHR_Cancer |
590 |
0.709512 |
0.783892 |
1.596332 |
| 2000 to 2008 |
Canada |
CIHR_Cancer |
338 |
1.168004 |
1.427612 |
1.643661 |
| 2000 to 2008 |
Italy |
CIHR_Cancer |
298 |
0.966617 |
1.087913 |
1.519722 |
| 2000 to 2008 |
Japan |
CIHR_Cancer |
225 |
0.830089 |
0.849565 |
0.594862 |
| 2000 to 2008 |
France |
CIHR_Cancer |
209 |
0.862078 |
1.136352 |
0.784825 |
| 2000 to 2008 |
Netherlands |
CIHR_Cancer |
184 |
1.253994 |
1.417071 |
1.623853 |
| 2000 to 2008 |
Australia |
CIHR_Cancer |
180 |
1.097907 |
1.315437 |
1.358602 |
| 2000 to 2008 |
Sweden |
CIHR_Cancer |
129 |
0.919138 |
1.249293 |
1.549639 |
« Back to figure 3
Figure 4: ICR investment in cancer research by theme, 2000–2010
| |
2000-01 |
2001-02 |
2002-03 |
2003-04 |
2004-05 |
2005-06 |
2006-07 |
2007-08 |
2008-09 |
2009-10 |
| Biomedical |
0 |
182,101 |
772,500 |
1,552,835 |
3,071,932 |
2,864,351 |
3,151,743 |
2,852,371 |
3,392,398 |
3,278,115 |
| Clinical |
0 |
7,500 |
2,090,000 |
2,259,162 |
804,009 |
1,404,527 |
762,091 |
1,540,238 |
1,243,917 |
1,197,195 |
| Health systems |
0 |
0 |
0 |
447,140 |
185,000 |
311,008 |
219,406 |
1,744,629 |
1,822,810 |
2,226,139 |
| Population Health |
0 |
11,105 |
124,987 |
355,021 |
394,212 |
987,744 |
456,330 |
1,002,447 |
864,499 |
565,163 |
| Not Specified |
0 |
21,812 |
907,600 |
673,000 |
2,296,778 |
952,614 |
1,867,745 |
1,230,019 |
1,114,402 |
1,633,777 |
« Back to figure 4
- Date modified:
-